SciSparc Ltd. (SPRC)
NASDAQ: SPRC · IEX Real-Time Price · USD
0.643
-0.087 (-11.87%)
At close: Jul 19, 2024, 4:00 PM
0.621
-0.022 (-3.44%)
Pre-market: Jul 22, 2024, 7:47 AM EDT
SciSparc Revenue
In the year 2023, SciSparc had annual revenue of $793.11K with 108.44% growth.
Revenue (ttm)
$793.11K
Revenue Growth
+108.44%
P/S Ratio
0.55
Revenue / Employee
$959,667
Employees
3
Market Cap
1.58M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 793.11K | 412.61K | 108.44% |
Dec 31, 2022 | 380.51K | - | - |
Dec 31, 2021 | 0 | - | - |
Dec 31, 2020 | 0 | - | - |
Dec 31, 2019 | 0 | - | - |
Dec 31, 2018 | 0 | - | - |
Dec 31, 2017 | 0 | - | - |
Dec 31, 2016 | 0 | - | - |
Dec 31, 2015 | 0 | - | - |
Dec 31, 2014 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
LogicMark | 9.73M |
Nuwellis | 8.90M |
SCWorx | 3.92M |
Assure Holdings | 1.63M |
Azitra | 572.70K |
IMAC Holdings | -2.09M |
SPRC News
- 5 days ago - SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 million - GlobeNewsWire
- 5 days ago - SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification - GlobeNewsWire
- 6 days ago - SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss - GlobeNewsWire
- 13 days ago - SciSparc Signs Non-Binding Letter of Intent for Spin Off of Advanced Clinical Stage Pharmaceutical Portfolio to Publicly Traded Company - GlobeNewsWire
- 7 weeks ago - SciSparc Secures Strategic Advantage with Grant of European Patent - GlobeNewsWire
- 2 months ago - Action Alliance Research: Family, Friends Need More Resources and Support to Help Loved Ones Who Are Struggling with Their Mental Health - Business Wire
- 3 months ago - SciSparc to Acquire AutoMax - GlobeNewsWire
- 4 months ago - SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression - GlobeNewsWire